Solbec Soared When One Mouse Lived

In an example of the market trading on less than complete information, Solbec Pharmaceuticals shares rose almost 70 per cent after it announced that its cancer drug Coramsine had induced remission of mesothelioma in mice. There was no mention in its statement of the number of mice treated or cured, or the testing method.